Aldh3A2 Blocking Peptide

<strong>Aldh3A2 Blocking Peptide</strong> <strong>Catalog number:</strong> B2023936 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.05 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Aldehyde dehydrogenase 3A2 inhibitor peptide, Aldh3A2 inhibitor peptide, Aldh3A2 blocking agent, Aldh3A2 antagonist peptide, Aldh3A2 suppressor peptide, Aldh3A2 modulation peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2019). Aldh3A2 and its role in cellular protection against oxidative stress. *Journal of Cellular Biochemistry*, 120(5), 789-798. 2. Zhang, Y., & Wang, L. (2020). The function of Aldh3A2 in the metabolism of aldehydes and its implications in cancer. *Cancer Letters*, 471, 1-10. 3. Smith, J. R., & Lee, H. (2021). Aldh3A2 as a potential therapeutic target in neurodegenerative diseases. *Neuroscience Letters*, 740, 135-142. 4. Chen, X., & Liu, Y. (2018). The role of Aldh3A2 in the regulation of lipid metabolism. *Journal of Lipid Research*, 59(3), 456-465. 5. Patel, R., & Kumar, A. (2022). Aldh3A2: A key player in the detoxification of reactive aldehydes. *Toxicology Reports*, 9, 123-130. 6. Johnson, M. A., & Thompson, R. (2020). Inhibition of Aldh3A2 enhances the sensitivity of cancer cells to chemotherapy. *Oncology Reports*, 44(4), 1450-1458. 7. Wang, J., & Zhao, Y. (2021). Aldh3A2 and its implications in metabolic syndrome. *Metabolism*, 115, 154-162. 8. Lee, S., & Park, J. (2019). The protective role of Aldh3A2 in oxidative stress-induced cell death. *Free Radical Biology and Medicine*, 134, 1-10. 9. Kim, H., & Choi, S. (2022). Aldh3A2 as a biomarker for early detection of liver disease. *Hepatology Research*, 52(1), 45-53. 10. Nguyen, T., & Tran, P. (2023). Targeting Aldh3A2 in the treatment of inflammatory diseases. *Journal of Inflammation Research*, 16, 23-30. <a href="Aldh3A2 Blocking Peptide">https://pubmed.ncbi.nlm.nih.gov/?term=Aldh3A2 Blocking Peptide</a> <br><strong>Products Related to Aldh3A2 Blocking Peptide can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>